Cizzle Biotechnology Holdings Plc (LON:CIZ)
London · Delayed Price · Currency is GBP · Price in GBX 1.100
-0.300 (-21.43%)
Oct 15, 2026, 3:52 PM GMT
LON:CIZ Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.08 | 0.12 | 0.37 | 0.14 | 0.48 | 0.88 |
Trading Asset Securities | - | - | 0.02 | 1.41 | - | - |
Cash & Short-Term Investments | 0.08 | 0.12 | 0.39 | 1.56 | 0.48 | 0.88 |
Cash Growth | -55.50% | -70.03% | -75.14% | 225.73% | -45.37% | 12400.00% |
Other Receivables | 0.11 | 0.1 | 0.08 | 0.11 | 0.1 | 0.05 |
Receivables | 0.11 | 0.1 | 0.08 | 0.11 | 0.1 | 0.05 |
Inventory | - | - | 0 | - | - | - |
Prepaid Expenses | - | 0.03 | 0.03 | 0.03 | 0.01 | 0.03 |
Other Current Assets | - | - | - | - | 0.12 | - |
Total Current Assets | 0.19 | 0.24 | 0.49 | 1.69 | 0.71 | 0.96 |
Property, Plant & Equipment | 0 | 0 | - | - | - | - |
Other Intangible Assets | - | - | - | - | 2.08 | 0.2 |
Total Assets | 0.19 | 0.25 | 0.49 | 1.69 | 2.79 | 1.16 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.53 | 0.05 | 0.01 | 0.09 | 0.04 | 0.11 |
Accrued Expenses | - | 0.53 | 0.4 | 0.09 | 0.1 | 0.11 |
Total Current Liabilities | 0.53 | 0.59 | 0.41 | 0.19 | 0.15 | 0.22 |
Total Liabilities | 0.53 | 0.59 | 0.41 | 0.19 | 0.15 | 0.22 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 3.51 | 3.51 | 3.51 | 3.5 | 3.5 | 3.49 |
Additional Paid-In Capital | 36.14 | 35.91 | 35.91 | 35.34 | 34.92 | 32.57 |
Retained Earnings | -10.92 | -10.59 | -10.04 | -7.87 | -6.15 | -5.52 |
Comprehensive Income & Other | -29.07 | -29.17 | -29.3 | -29.46 | -29.63 | -29.61 |
Shareholders' Equity | -0.34 | -0.34 | 0.08 | 1.51 | 2.64 | 0.94 |
Total Liabilities & Equity | 0.19 | 0.25 | 0.49 | 1.69 | 2.79 | 1.16 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 0.08 | 0.12 | 0.39 | 1.56 | 0.48 | 0.88 |
Net Cash Growth | 153.13% | -70.03% | -75.14% | 225.73% | -45.37% | - |
Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Filing Date Shares Outstanding | 404.4 | 396.39 | 396.39 | 363.84 | 339.8 | 253.45 |
Total Common Shares Outstanding | 404.4 | 396.39 | 396.39 | 363.84 | 339.8 | 253.45 |
Working Capital | -0.34 | -0.34 | 0.08 | 1.51 | 0.56 | 0.74 |
Book Value Per Share | -0.00 | -0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
Tangible Book Value | -0.34 | -0.34 | 0.08 | 1.51 | 0.56 | 0.74 |
Tangible Book Value Per Share | -0.00 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 |